Presented by
Management Forum
Lunch & Learn
In this talk, explore the fundamental concepts, techniques, and processes that make up the backbone of biomanufacturing, pharmaceutical production, and biotechnology.
4 April 2025
+ 12 September 2025, 5 December 2025 »
from £175
You may also be interested in...
Part of Lunch & Learn: Molecule to Medicine series:
Are you seeking an understanding of the steps that turn scientific innovations into therapeutic products? This exciting series provides a concise overview of the drug development process, from early-stage research through to the creation of medicines. Participants will learn about key topics such as molecule discovery, preclinical testing, clinical trials, and the regulatory processes involved in bringing a medicine to market.
From £99! Our Lunch & Learn short courses start from just £99 (early booking price) when you book 5 or more places - any combination of multiple courses for one attendee, or multiple attendees on the same course.
Bioprocessing is the use of biological systems (such as cells, enzymes, or microorganisms) to produce valuable products, like pharmaceuticals, biofuels, or specialty chemicals. This process is typically broken down into two main stages: upstream processing and downstream processing. Both play vital roles in ensuring the efficient production, purification, and quality control of the final product.
Upstream processing encompasses everything that occurs before the actual production of the product, and it’s primarily concerned with creating an optimal environment for microorganisms or cell cultures to grow and produce the target product.
Once the biological system has generated the product in upstream processing, the focus shifts to downstream processing, which involves purification and formulation to ensure the product is safe, pure, and suitable for commercial use.
Upstream and downstream processes are interconnected. The choice of cell culture methods, fermentation conditions, and media formulation can significantly affect the yield and purity of the product, which in turn impacts the complexity and cost of downstream processing.
This course is part of our GxP training (Good x Practice) course collection, which features a variety of topic areas to ensure you comply with the most recent quality guidelines. For more information on the latest EU GMP regulations, see our GMP training course covering the Annex 1.
Attending this session will not only deepen your knowledge but also equip you with the practical tools and strategies needed to enhance both upstream and downstream manufacturing processes, improve product quality, and navigate the complexities of the biopharmaceutical industry. The benefits of attending this session include:
Mustafa Edik is an Independent GMP Consultant and Auditor.
After graduating as a Chemist from university, Mustafa began his 25 year plus career as a Laboratory Supervisor at Bayer, a German Pharmaceutical Company. After 15 years of working as a Quality Assurance Assistant Manager, Laboratory Supervisor, Pharmaceutical Quality Management Systems, and GMP Lead Auditor, he decided to continue his career as a Consultant. He has served the Turkish Atomic Energy Authority (TAEA) as Principal GMP Auditor and Consultant for 6 years. TAEA was audited by the Republic of Turkey Ministry of Health and granted GMP Certificate for 5 Radiopharmaceuticals. This success has won great acclaim from all health authorities and industry.
He has prepared and presented various training courses and workshops to more than 8000 individuals from 150 International and local Pharmaceutical, Medical Device, and Cosmetics companies on GMP, GDP and Pharmaceutical Quality Management Systems. He has taken part in several International Pharmaceutical Facility Establishment projects as GMP Consultant and has also set up various Quality Management Systems for Local Pharmaceutical and Medical Device Companies.
While he was the Vice President of Quality and Technical Operations at a Quality Academia Training and Consultancy firm, he acquired and converted it into a 100 % Turkish Company. As the only IRCA Certificated Pharmaceutical Quality Management Systems and GMP Lead Auditor in Turkey, he currently conducts API, Excipient, Packaging Materials Suppliers and Manufacturers, Third Party Logistics Service Providers, Sterile and Non-Sterile Manufacturing Facilities Audits according to FDA, EMA, PIC /S, TMMDA, MHRA, TGA Health Canada, and WHO regulations and guidelines.
He finished his second university degree in Biopharmaceutical Sciences BSc (Hons) at Atlantic Technological University - Ireland. He is the author of chapter 6 of the book published by PDA named “Good Distribution Practices” and his new book on ‘GMP Audits in Pharmaceutical and Biotechnology Industires’ will be published by Taylor & Francis in June 28, 2024.
4 April 2025
Lunch & Learn
Live online
12:00-13:30 UK (London) (UTC+01)
13:00-14:30 Paris (UTC+02)
07:00-08:30 New York (UTC-04)
Course code 15519
Until 28 Feb
Not ready to book yet?
for 7 days, no obligation
12 September 2025
Lunch & Learn
Live online
12:00-13:30 UK (London) (UTC+01)
13:00-14:30 Paris (UTC+02)
07:00-08:30 New York (UTC-04)
Course code 15520
Until 08 Aug
Not ready to book yet?
for 7 days, no obligation
5 December 2025
Lunch & Learn
Live online
12:00-13:30 UK (London) (UTC+00)
13:00-14:30 Paris (UTC+01)
07:00-08:30 New York (UTC-05)
Course code 15521
Until 31 Oct
Not ready to book yet?
for 7 days, no obligation
* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.
Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to: